HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Benjamin K Yee Selected Research

2- chloro- N- ((S)- phenyl((2S)- piperidin- 2- yl)methyl)- 3- trifluoromethyl benzamide

8/2009Interactions between the glycine transporter 1(GlyT1) inhibitor SSR504734 and psychoactive drugs in mouse motor behaviour.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Benjamin K Yee Research Topics

Disease

23Schizophrenia (Dementia Praecox)
01/2015 - 01/2005
4Neurobehavioral Manifestations
01/2015 - 03/2006
4Infections
05/2010 - 01/2005
2Inflammation (Inflammations)
01/2019 - 05/2006
2Alzheimer Disease (Alzheimer's Disease)
06/2013 - 08/2008
2Memory Disorders (Memory Loss)
08/2012 - 04/2012
2Psychotic Disorders (Schizoaffective Disorder)
05/2010 - 07/2008
2Cognitive Dysfunction
07/2008 - 09/2007
1Autism Spectrum Disorder
01/2020
1Peripheral Nervous System Diseases (PNS Diseases)
11/2013
1Hyperekplexia
11/2013
1Alcoholism (Alcohol Abuse)
11/2013
1Epilepsy (Aura)
11/2013
1Pain (Aches)
11/2013
1Iron Deficiencies
08/2012
1Autistic Disorder (Autism)
05/2008
1Shock
04/2007
1Parkinson Disease (Parkinson's Disease)
10/2004

Drug/Important Bio-Agent (IBA)

7Antipsychotic Agents (Antipsychotics)IBA
01/2015 - 02/2008
5N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2015 - 03/2006
5Glycine Plasma Membrane Transport ProteinsIBA
01/2015 - 07/2008
5Dopamine (Intropin)FDA LinkGeneric
04/2013 - 10/2004
4Amphetamine (Amfetamine)FDA LinkGeneric
01/2010 - 04/2007
3Glutamic Acid (Glutamate)FDA Link
01/2015 - 03/2012
3Adenosine (Adenocard)FDA LinkGeneric
04/2013 - 03/2012
3CytokinesIBA
09/2009 - 01/2005
2N-Methylaspartate (NMDA)IBA
01/2015 - 11/2009
2Glycine (Aminoacetic Acid)FDA LinkGeneric
11/2013 - 03/2006
2Cholinergic Agents (Cholinergics)IBA
06/2013 - 03/2012
2AcidsIBA
05/2008 - 01/2005
1EndocannabinoidsIBA
01/2020
1Therapeutic UsesIBA
01/2019
1LipidsIBA
01/2019
1Nucleic AcidsIBA
01/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
01/2015
1(4- (3- fluoro- 5- trifluoromethylpyridin- 2- yl)piperazin- 1- yl)(5- methanesulfonyl- 2- (2,2,2- trifluoro- 1- methylethoxy)phenyl)methanoneIBA
01/2015
1Biomarkers (Surrogate Marker)IBA
10/2013
1Nootropic Agents (Nootropics)IBA
01/2013
1Fatty Acids (Saturated Fatty Acids)IBA
08/2012
1IronIBA
08/2012
1Neurotransmitter Agents (Neurotransmitter)IBA
03/2012
1Scopolamine (Hyoscine)FDA Link
03/2012
1Cholinergic Antagonists (Anticholinergics)IBA
03/2012
1Antidepressive Agents (Antidepressants)IBA
05/2010
1Nogo ReceptorsIBA
01/2010
1Phencyclidine (Angel Dust)IBA
11/2009
1Clozapine (Clozaril)FDA LinkGeneric
11/2009
12- chloro- N- ((S)- phenyl((2S)- piperidin- 2- yl)methyl)- 3- trifluoromethyl benzamideIBA
08/2009
1Amyloid beta-PeptidesIBA
08/2008
1GABA-A Receptors (GABA(A) Receptor)IBA
07/2008
1Brain-Derived Neurotrophic Factor (BDNF)IBA
09/2007
1Poly I-CIBA
07/2006

Therapy/Procedure

3Therapeutics
01/2015 - 07/2012
3Drug Therapy (Chemotherapy)
03/2012 - 12/2007